Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61:675-681): 675-681)

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	159-160
Number of pages	2
Journal	European Journal of Clinical Pharmacology
Volume	62
Issue number	2
DOIs	https://doi.org/10.1007/s00228-005-0074-y
Publication status	Published - Feb-2006

Access to Document

Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005
Final publisher's version, 57 KB
Request copy

@article{5224657b348f4567984521c9cbac77c4,

title = "Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61:675-681): 675-681)",

author = "Mark Naunton and M Duyvendak and G.M. Peterson and J.R.B.J. Brouwers",

year = "2006",

month = feb,

doi = "10.1007/s00228-005-0074-y",

language = "English",

volume = "62",

pages = "159--160",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61:675-681)

T2 - 675-681)

AU - Naunton, Mark

AU - Duyvendak, M

AU - Peterson, G.M.

AU - Brouwers, J.R.B.J.

PY - 2006/2

Y1 - 2006/2

U2 - 10.1007/s00228-005-0074-y

DO - 10.1007/s00228-005-0074-y

M3 - Letter (Research letter)

SN - 0031-6970

VL - 62

SP - 159

EP - 160

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 2

ER -